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ABSTRACT; 
Background; Nephrotic syndrome (NS) is one of the most common renal diseases found in the paediatric 
population and is associated with significant complications, including infection and thrombosis. A high 
proportion of children enter sustained remission before adulthood, and therapy must therefore mitigate the 
childhood complications, while minimising the long-term risk to health. Objective; To determine the frequency 
of hypertension in children with nephrotic syndrome presenting at a tertiary care hospital. Material and 
Methods; All the patients (n = 146) who meet inclusion of this study were registered from OPD of Department 
of Pediatrics, Nishtar Hospital, Multan, Pakistan. Informed consent was taken from the parents of these children 
describing them objectives of this study, ensuring them confidentiality of the information provided and fact that 
there was no risk involved to the patient while taking part in this study. Children with steroid sensitive nephrotic 
syndrome were taken in this study. Systolic and diastolic blood pressure was measured by researcher. Results; 
Of these 146 study cases, 92 (63%) were male patients while 54 (37 %) were female patients. Mean age of our 
study cases was 7.61 ± 2.55 years. Our study results have indicated that majority of our study cases i.e. 91 (62.3 
%) were aged more than 7 years. Of these 146 study cases, 76 (52.1 %) belonged to rural areas and 70 (47.9 %) 
belonged to urban areas. Positive family history was noted in 11 (7.5%) and 129 (88.4%) mothers of these 
patients were illiterate. Compliance with the treatment was noted only in 31 (21.2%) of our study cases. Mean 
disease duration was 18.51 ± 10.26 months and 86 (58.9%) had duration of illness more than 12 months. Mean 
duration of treatment was 6.58± 2.28 months and 113 (77.4%) were taking their treatment for equal/less than 1 
year. Mean systolic blood pressure was 135.85 ± 5.12 mmHg while diastolic blood pressure was 90.87 ± 3.25 
mmHg. Hypertension was noted in 54 (37%) of our study cases. Conclusion; Frequency of hypertension was 
high among children having nephrotic syndrome in our study. Hypertension was significantly associated with 
family history, treatment compliance and prolonged disease duration. All clinicians treating such patients should 
monitor such children for hypertension for timely diagnosis and early management which will improve clinical 
outcomes and decrease disease morbidity. This will help to improve quality of life of our patients and also save 
them from future hardships.  
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INTRODUCTION; 
Nephrotic syndrome refers to the tetrad of edema, ‘nephrotic- range’ proteinuria, hypoalbuminemia, and 
hyperlipidemia. Nephrotic- range proteinuria in the pediatric age group is defined as protein excretion of more 
than 40 mg/m2/hour. In children, 24 hour-urine collections are unreliable. Thus, a single, first morning urine 
sample is now preferably used to quantify protein excretion by the estimation of the urine protein/creatinine 
ratio. From the new management guidelines released by the Kidney Disease: Improving Global Outcomes 
(KDIGO) group, urine protein/creatinine ratio of ≥ 2000 mg/g correlates with ‘nephrotic-range’ proteinuria or 
dip-stick proteinuria of 3+ 
1,2
. Nephrotic syndrome remains the most common manifestation of glomerular 
disease in childhood 
3
. The disease progresses to frequent relapses, often accompanied by steroid dependence in 
about 20% to 60% of patients.
4 
It is currently recognized that at least 50% of relapses are triggered by a viral 
upper respiratory tract infection.5  
Nephrotic syndrome (NS) is the most common glomerular disease of childhood 
6
. Most caucasian series report 
NS as a disease of pre-school aged children with peak age incidence of 2-3 years, affecting more males than 
females. Seventy to 90% of such cases are due to minimal change lesions in which hypertension, haematuria and 
poor response to steroid therapy are uncommon. In nephrotic syndrome protein leaks from the blood to the urine 
through the glomeruli resulting in hypoproteinaemia and generalised oedema. While most children with 
nephrotic syndrome respond to corticosteroids, 80% experience a relapsing course. Corticosteroids have reduced 
the mortality rate to around 3%. However corticosteroids have well recognised potentially serious adverse effects 
such as obesity, poor growth, hypertension, diabetes mellitus, osteoporosis and behavioural disturbances 
7.Hypertension has been reported to be 41.4% among children with nephrotic syndrome 8. A study from 
Bangladesh reported 15.8 % hypertension by disease plus taking prednisolone in children with nephrotic 
syndrome. 
9 
Another retrospective analysis from Islamabad documented nephrotic syndrome associated with 
64% hypertension in children 10. 
This study is designed to ascertain the frequency of hypertension among children with nephritic syndrome owing 
to the corticosteroid therapy which has well documented side effect including hypertension.  
 
MATERIAL AND METHODS; 
Children (n = 146) aged 2-12 years of either sex having nephrotic syndrome for more than 6 months were 
included in our descriptive cross-sectional study. Patients with congenital nephrotic syndrome, secondary 
nephrotic syndrome e.g. TB, Hepatitis, malaria and drugs/toxins, known cases with the history of Asthma and 
known congenital heart defects were excluded from our study.  
A specialized proforma has been developed to record the findings of this study. All the patients (n = 146) who 
meet inclusion of this study were registered from OPD of Department of Pediatrics, Nishtar Hospital, Multan, 
Pakistan. Informed consent was taken from the parents of these children describing them objectives of this study, 
ensuring them confidentiality of the information provided and fact that there was no risk involved to the patient 
while taking part in this study. Children with steroid sensitive nephrotic syndrome were taken in this study. 
Systolic and diastolic blood pressure was measured by researcher. Nephrotic syndrome; was defined by the 
presence of all of the followings; nephrotic-range proteinuria (urinary protein loss in excess of 0.05 – 0.1 g/kg 
body weight/day) or (+++) proteinuria on dipstick for 3 consecutive days, generalized edema and 
hypoalbuminemia (Serum Albumin level less than 2.5 g/dl).  
Hypertension; was diagnosed if a child’s BP is greater than the 95th percentile but less than or equal to the 99th 
percentile plus 5 mm Hg
11
; 
o Equal or Less than 6 Years age; For boys 120/80 and girls 119/79 mm Hg on two different 
occasions 24 hours apart. 
o More than 6 years of age; For boys 130/87 and girls 129/86 mm Hg on two different 
occasions 24 hours apart. 
All the data was entered and analyzed using SPSS-18. Descriptive statistics was applied to calculate mean and 
standard deviation for the age of the children, duration on corticosteroid therapy, blood pressure and duration of 
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illness. Frequencies and percentages were tabulated for the categorical variables like age groups, treatment 
compliance, family history, maternal education, residential status, gender and hypertension (Yes/No).  
 
RESULTS; 
Our study comprised of a total of 146 patients meeting inclusion criteria of our study. Of these 146 study cases, 
92 (63%) were male patients while 54 (37 %) were female patients. Mean age of our study cases was 7.61 ± 2.55 
years (with minimum age of our study cases was 2 years while maximum age was 12 years). Mean age of the 
male patients was noted to be 7.37 ± 2.95 years while that female patients was 8.02 ± 1.61 years (p=0.139). Our 
study results have indicated that majority of our study cases i.e. 91 (62.3 %) were aged more than 7 years. Of 
these 146 study cases, 76 (52.1 %) belonged to rural areas and 70 (47.9 %) belonged to urban areas. Positive 
family history was noted in 11 (7.5%) and 129 (88.4%) mothers of these patients were illiterate. Compliance 
with the treatment was noted only in 31 (21.2%) of our study cases. Mean disease duration was 18.51 ± 10.26 
months and 86 (58.9%) had duration of illness more than 12 months. Mean duration of treatment was 6.58± 2.28 
months and 113 (77.4%) were taking their treatment for equal/less than 1 year. Mean systolic blood pressure was 
135.85 ± 5.12 mmHg while diastolic blood pressure was 90.87 ± 3.25 mmHg. Hypertension was noted in 54 
(37%) of our study cases.  
 
Table No. 1 
Stratification of Hypertension with regards to family history. 
(n = 146) 
Family History  
Hypertension 
P – value  Yes 
(n=54) 
No 
(n=92) 
Yes 
(n=11) 
00 11 
0.007 
No 
(n=135) 
54 81 
 
Total 
 
146 
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Table No. 2 
Stratification of Hypertension with regards to treatment compliance. 
Treatment 
compliance  
Hypertension 
P – value  Yes 
(n=54) 
No 
(n=92) 
Yes 
(n=31) 
00 31 
0.000 
No 
(n=115) 
54 61 
 
Total 
 
146 
 
Table No. 3 
Stratification of Hypertension with regards to disease duration. 
(n = 146) 
Disease duration 
Hypertension 
P – value  Yes 
(n=54) 
No 
(n=92) 
Up to 1 Year 
(n=60) 
10 50 
0.000 
More than 1 Year 
(n=86) 
44 42 
 
Total 
 
146 
 
DISCUSSION; 
Nephrotic syndrome refers to the tetrad of edema, ‘nephrotic- range’ proteinuria, hypoalbuminemia, and 
hyperlipidemia 
12,13
. Nephrotic- range proteinuria in the pediatric age group is defined as protein excretion of 
more than 40 mg/m2/hour. In children, 24 hour-urine collections are unreliable. Thus, a single, first morning 
urine sample is now preferably used to quantify protein excretion by the estimation of the urine 
protein/creatinine ratio
14
. From the new management guidelines released by the Kidney Disease: Improving 
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Global Outcomes (KDIGO) group, urine protein/creatinine ratio of ≥ 2000 mg/g correlates with ‘nephrotic-
range’ proteinuria or dip-stick proteinuria of 3+. 
15, 16
 
Our study comprised of a total of 146 patients meeting inclusion criteria of our study. Of these 146 
study cases, 92 (63%) were male patients while 54 (37 %) were female patients. Different studies done in 
children with steroid sensitive nephrotic syndrome have documented male gender predominance as has been 
reported in our study. Abeyagunawardena et al 
17
 also reported similar results showing male gender 
predominance. Arun et al 18 reported 67.5 % male gender predominance in children treated with Zn while 63.4 % 
in those treated with placebo. These findings are similar to that of our study results. Sherali et al 19 also reported 
male gender predominance with 72 % in Zn group while 76 % in placebo group which is same as that of our 
study results.  
Mean age of our study cases was 7.61 ± 2.55 years (with minimum age of our study cases was 2 years 
while maximum age was 12 years). Mean age of the male patients was noted to be 7.37 ± 2.95 years while that 
female patients was 8.02 ± 1.61 years (p=0.139). Our study results have indicated that majority of our study 
cases i.e. 91 (62.3 %) were aged more than 7 years. Arun et al 
18 
also reported 95.2 ± 41.8 months mean age in 
children treated with Zinc while 88.4 ± 38.3 months in children treated with placebo. These results are similar to 
that of our study results. Sherali 19 reported 7.65 ± 3.20 years mean age of these patients. These results are 
similar to that of our study results.  
Of these 146 study cases, 76 (52.1 %) belonged to rural areas and 70 (47.9 %) belonged to urban areas. 
Positive family history was noted in 11 (7.5%) and 129 (88.4%) mothers of these patients were illiterate. 
Compliance with the treatment was noted only in 31 (21.2%) of our study cases. Mean disease duration was 
18.51 ± 10.26 months and 86 (58.9%) had duration of illness more than 12 months. Mean duration of treatment 
was 6.58± 2.28 months and 113 (77.4%) were taking their treatment for equal/less than 1 year.  
Mean systolic blood pressure was 135.85 ± 5.12 mmHg while diastolic blood pressure was 90.87 ± 3.25 
mmHg. Hypertension was noted in 54 (37%) of our study cases. A study conducted by Ibadin et al  8 has reported 
hypertension to be 41.4% among children with nephrotic syndrome 
8
. These findings of Ibadin et al 
8
 are close to 
our study results. A study from Bangladesh by Roy et al 
8
 reported 15.8 % hypertension
9 
which is quite lower 
than that of our study results. Another retrospective analysis from Islamabad documented nephrotic syndrome 
associated with 64% hypertension in children 
10
 which is quite higher than that of our findings.  
 
CONCLUSION;  
Frequency of hypertension was high among children having nephrotic syndrome in our study. Hypertension was 
significantly associated with family history, treatment compliance and prolonged disease duration. All clinicians 
treating such patients should monitor such children for hypertension for timely diagnosis and early management 
which will improve clinical outcomes and decrease disease morbidity. This will help to improve quality of life of 
our patients and also save them from future hardships.  
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